C522-0759 Screening compound: 1-{[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}piperidine-4-carboxamide

C522-0759 Screening compound: 1-{[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}piperidine-4-carboxamide
C522-0759 Screening compound: 1-{[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C522-0759
1-{[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C522-0759

Molecular Formula

C30H37Cl2N5O2 (C30 H37 Cl2 N5 O2)

Compound Name

1-{[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}piperidine-4-carboxamide

IUPAC name

1-{[2-(4-chlorophenyl)-5-methyl-13-oxazol-4-yl]methyl}-N-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}piperidine-4-carboxamide

SMILES

Cc1c(CN(CC2)CCC2C(NCCCN(CC2)CCN2c2cccc(Cl)c2)=O)nc(-c(cc2)ccc2Cl)o1

InChI

InChI=1S/C30H37Cl2N5O2/c1-22-28(34-30(39-22)24-6-8-25(31)9-7-24)21-36-14-10-23(11-15-36)29(38)33-12-3-13-35-16-18-37(19-17-35)27-5-2-4-26(32)20-27/h2,4-9,20,23H,3,10-19,21H2,1H3,(H,33,38)

InChI Key

YJALSEIZUVMCKW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14765703

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

570.56

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.608

Distribution Coefficient, logD

3.649

Water Solubility, LogSw

-4.63

Polar Surface Area

53.591

Acid Dissociation Constant (pKa)

15.07

Base Dissociation Constant (pKb)

8.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.70

C522-0759 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Human Kinases Annotated Library (2415 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with C522-0759 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C522-0759?
Check Price and Availability of C522-0759, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C522-0759 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C522-0759
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C522-0759
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C522-0759 available by request